Prenatal Risk Assessment

 

 

tox.JPG (37169 bytes)


MCL Laboratories

 

 

 

 

MCL Pathology Services
504-903-3885

 

 

The prenatal risk assessment (also called the "triple screen") is a group  of assays (AFP, BHCG and unconjugated Estriol (uE3)) in conjunction with prenatal risk assessment software to calculate risk for Down's Syndrome, Trisomy 18, and Neural tube defects. The testing is performed on a serum sample collected between weeks 15-21 (15 weeks 0 days to 20 weeks 6 days) of gestation.

MCL Web Resources a TCM Project

last revised 12/12/2005